Article
Dermatomyositis-like skin eruptions under hydroxyurea therapy conceal TP53-mutated atypical keratinocytes: A histopathologic and molecular pathologic case series.
Journal of cutaneous pathology - 1 Nov 2024
Pruessmann Wiebke, Kirfel Jutta, Sailer Verena-Wilbeth, Rose Christian
Abstract excerpt
Hydroxyurea is an antimetabolite that inhibits DNA synthesis and is used as a treatment option in chronic myeloproliferative disorders. Rarely, "dermatomyositis (DM)-like" skin lesions are observed after long-term therapy. In this case series, five skin biopsies of four patients were evaluated by histology, immunohistochemistry, and next-generation sequencing of the TP53 gene locus. All biopsies showed focal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
